-
1دورية أكاديمية
المؤلفون: Polite, Blase N., Cipriano-Steffens, Toni, Hlubocky, Fay, Dignam, James, Ray, Mandira, Smith, David, Undevia, Samir, Sprague, Evie, Olopade, Olufunmilayo, Daugherty, Christopher, Fitchett, George, Gehlert, Sarah
المصدر: Journal of Racial and Ethnic Health Disparities, 2017 Apr 01. 4(2), 140-148.
الوصول الحر: https://www.jstor.org/stable/48707783Test
-
2دورية أكاديمية
المؤلفون: Jones, Robin L, Ratain, Mark J, O'Dwyer, Peter J, Siu, Lillian L, Jassem, Jacek, Medioni, Jacques, DeJonge, Maja, Rudin, Charles, Sawyer, Michael, Khayat, David, Awada, Ahmad, de Vos-Geelen, Judith M P G M, Evans, T R Jeffry, Obel, Jennifer, Brockstein, Bruce, DeGreve, Jacques, Baurain, Jean-François, Maki, Robert, D'Adamo, David, Dickson, Mark, Undevia, Samir, Geary, David, Janisch, Linda, Bedard, Philippe L, Abdul Razak, Albiruni R, Kristeleit, Rebecca, Vitfell-Rasmussen, Joanna, Walters, Ian, Kaye, Stan B, Schwartz, Gary
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer
المصدر: European journal of cancer (Oxford, England : 1990), Vol. 120, p. 132-139 (2019)
مصطلحات موضوعية: Aged, Alanine, Antineoplastic Agents, Biomarkers, Tumor, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Prognosis, Survival Rate, Triazines, Withholding Treatment, Brivanib, FGF2 status, Ovarian cancer, Randomised discontinuation trial, Sarcomas, Solid tumours
العلاقة: boreal:237856; http://hdl.handle.net/2078.1/237856Test; info:pmid/31522033; urn:ISSN:0959-8049; urn:EISSN:1879-0852
-
3دورية أكاديمية
المؤلفون: Jones, Robin Lewis, Ratain, Mark M.J., O'Dwyer, Peter P.J., Siu, Lillian L, Jassem, Jacek, Medioni, Jacques, DeJonge, Maja, Rudin, Charles, Sawyer, Michael M.B., Khayat, David, Awada, Ahmad, de Vos-Geelen, Judith J.M.P.G.M., Evans, Thomas Ronald Jeffrey, Obel, Jennifer, Brockstein, Bruce, DeGreve, Jacques, Baurain, Jean-Francois, Maki, Robert, D'Adamo, David, Dickson, Mark, Undevia, Samir, Geary, David, Janisch, Linda, Bedard, Philippe L, Abdul Razak, Albiruni Ryan, Kristeleit, Rebecca, Vitfell-Rasmussen, Joanna, Walters, Ian, Kaye, Stan S.B., Schwartz, Gary
المصدر: European journal of cancer, 120
مصطلحات موضوعية: Cancérologie, Brivanib, FGF2 status, Ovarian cancer, Randomised discontinuation trial, Sarcomas, Solid tumours
وصف الملف: 1 full-text file(s): application/pdf
العلاقة: uri/info:doi/10.1016/j.ejca.2019.07.024; uri/info:pii/S0959804919304435; uri/info:pmid/31522033; uri/info:scp/85072047537; https://dipot.ulb.ac.be/dspace/bitstream/2013/297142/1/doi_280786.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/297142Test
-
4دورية أكاديمية
المؤلفون: Jones, Robin L., Ratain, Mark J., O'Dwyer, Peter J., Siu, Lillian L., Jassem, Jacek, Medioni, Jacques, DeJonge, Maja, Rudin, Charles, Sawyer, Michael, Khayat, David, Awada, Ahmad, de Vos-Geelen, Judith M.P.G.M., Evans, T.R. Jeffry, Obel, Jennifer, Brockstein, Bruce, DeGreve, Jacques, Baurain, Jean-Francois, Maki, Robert, D'Adamo, David, Dickson, Mark, Undevia, Samir, Geary, David, Janisch, Linda, Bedard, Philippe L., Abdul Razak, Albiruni R., Kristeleit, Rebecca, Vitfell-Rasmussen, Joanna, Walters, Ian, Kaye, Stan B., Schwartz, Gary
وصف الملف: text
العلاقة: http://eprints.gla.ac.uk/196435/1/196435.pdfTest; Jones, R. L. et al. (2019) Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. European Journal of Cancer , 120, pp. 132-139. (doi:10.1016/j.ejca.2019.07.024 ) (PMID:31522033)
-
5دورية أكاديمية
المؤلفون: Chow, Warren, Frankel, Paul, Ruel, Chris, Araujo, Dejka M., Milhem, Mohammed, Okuno, Scott, Hartner, Lee, Undevia, Samir, Staddon, Arthur
المساهمون: Novartis Pharmaceuticals Corporation
المصدر: Cancer ; volume 126, issue 1, page 105-111 ; ISSN 0008-543X 1097-0142
-
6دورية أكاديمية
المؤلفون: Schwartz, Gary K, Tap, William D, Qin, Li-Xuan, Livingston, Michael B, Undevia, Samir D, Chmielowski, Bartosz, Agulnik, Mark, Schuetze, Scott M, Reed, Damon R, Okuno, Scott H, Ludwig, Joseph A, Keedy, Vicki, Rietschel, Petra, Kraft, Andrew S, Adkins, Douglas, Van Tine, Brian A, Brockstein, Bruce, Yim, Vincent, Bitas, Christiana, Abdullah, Abdul, Antonescu, Cristina R, Condy, Mercedes, Dickson, Mark A, Vasudeva, Shyamprasad Deraje, Ho, Alan L, Doyle, L Austin, Chen, Helen X, Maki, Robert G
المساهمون: the National Cancer Institute
المصدر: The Lancet Oncology ; volume 14, issue 4, page 371-382 ; ISSN 1470-2045
مصطلحات موضوعية: Oncology
الإتاحة: https://doi.org/10.1016/s1470-2045Test(13)70049-4
https://api.elsevier.com/content/article/PII:S1470204513700494?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1470204513700494?httpAccept=text/plainTest -
7
-
8
-
9دورية أكاديمية
المؤلفون: Ryan, Christopher W., Montag, Anthony G., Hosenpud, Janet R., Samuels, Brian, Hayden, James B., Hung, Arthur Y., Mansoor, Atiya, Peabody, Terrance D., Mundt, Arno J., Undevia, Samir
المصدر: Cancer ; volume 112, issue 11, page 2432-2439 ; ISSN 0008-543X 1097-0142
-
10دورية أكاديمية
المؤلفون: Posadas, Edwin M., Undevia, Samir, Manchen, Elizabeth, Wade, James L., Colevas, Dimitrios, Karrison, Theodore, Vokes, Everett, Stadler, Walter M.
المصدر: Cancer Biology & Therapy ; volume 6, issue 4, page 490-493 ; ISSN 1538-4047 1555-8576